Michiel Vermeulen
Stichting Radboud Universitet (RU)
Biosketch
Michiel Vermeulen studies gene expression regulation in health and disease using integrative omics approaches. He pioneered the application of quantitative interaction proteomics to identify and characterise proteins that specifically interact with epigenetic modifications (i.e. Cell 2007, Cell 2010, Cell 2013). He also published the first global interactomes for the mRNA modification m6A (NSMB 2017), ubiquitin linkages (Mol. Cell 2017) and ADP ribosylation (Mol. Cell 2021). Furthermore, he characterized a number of chromatin-associated proteins, which regulate embryonic and adult stem cell differentiation (i.e. NSMB 2016, Mol. Sys. Biol. 2019). In total, he authored > 150 scientific publications. Major grants include NWO-VIDI (2009) and VICI (2021), an ERC Starter (2012) and Consolidator (2017) grant and various other EU grants (i.e. Marie Curie ITN networks DevCom (FP7) and EpiSystem (H2020)). In 2019 he was elected as a member of Academia Europaea and in 2022 he was elected as member of EMBO
Selected publications
Description of partner organization
The Vermeulen lab is hosted by the Radboud Institute for Molecular Life Sciences (RIMLS) at the Radboud University Nijmegen, The Netherlands. The mission of the institute is to integrate fundamental questions and technologies in the life sciences with medical applications, with the ultimate aim being to have a significant impact on healthcare
By using the site, you agree to our use of cookies. More info
This site uses cookies to provide the best browsing experience possible. By continuing to use this site without changing your cookie settings or by clicking on "Accept" you allow their use.